DashboardAll companies
Run this on your own research
Common Stock · Common Stock

Naturecell Co., Ltd.

007390KRX₩21,900−₩100 (−0.45%)Market closed

Price Chart

Daily

Key facts

Market Cap
₩1.41T
P/E
−496.9x
P/B
22.38x
ROE
−4.4%

Naturecell Co., Ltd.

Common Stock · Common Stock · FY 2025

Naturecell Co., Ltd. is a biotechnology company primarily focused on the development, production, and commercialization of cell therapy products. The company operates in the burgeoning biopharmaceutical industry, aiming to leverage stem cell technologies to offer innovative treatment options for a range of medical conditions. It engages in research and development efforts to create therapies that can enhance regenerative processes in the human body, particularly targeting diseases that currently have limited treatment avenues. Naturecell Co., Ltd. is dedicated to advancing therapeutic solutions that can address unmet medical needs, potentially impacting healthcare outcomes significantly. The company’s presence in the market underscores the growing importance of biotechnology and regenerative medicine in modern healthcare. By investing in cutting-edge research and employing advanced biotechnologies, Naturecell Co., Ltd. plays a critical role in the evolution of medical treatments, positioning itself as a key player in the sector. With its focus on innovation and the application of cell therapy, the firm contributes to the broader objective of developing sustainable and effective healthcare solutions worldwide.

CEO
변대중
Employees
0

Company Statistics

Valuation

P/E
−496.9x
P/B
22.38x
P/S
68.02x
EV/EBITDA
−2,468.3x
P/FCF
−85.8x

Margins

Gross
45.6%
EBITDA
−2.7%
Operating
−17.5%
Pre-Tax
−13.3%
Net
−13.7%

Returns

ROA
−3.9%
ROE
−4.4%
ROIC
−3.5%

Growth (CAGR)

Rev 3Yr
−0.8%
Rev 5Yr
4.4%
Op Inc 3Yr
—
Net Inc 3Yr
—

Financial Health

Cash & Cash Equivalents
₩16.77B
Net Debt
−₩5.07B
Debt/Equity
18.6%
Interest Cov
—

Profile

Revenue
₩20.73B
Shares Out
64.4M
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Naturecell Co., Ltd. (007390) Stock Forecast 2026 ₩21,900 — Price, Financials & Analyst Targets | AlphaLenz